ALT Stock-Based Compensation
Altimmune Inc · Stock-Based Compensation
ALT Stock-Based Compensation
Latest reported$14.66Mperiod ending
ALT Stock-Based Comp ($0.00 → $14.66M)
Annual stock-based compensation
High-resolution chart · PNG
ALT stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 16,076,000 | |
| 14,393,000 | |
| 10,640,000 | |
| 8,101,000 | |
| 5,519,000 | |
| 2,576,006 | |
| 0 | |
| 773,248 | |
| 1,443,492 | |
| 2,240,015 | |
| 613,017 | |
| 1,655,647 | |
| 1,362,716 | |
| 1,894,099 | |
| 2,565,961 | |
| 2,513,159 | |
| 3,444,275 | |
| 3,041,146 | |
| 0 | |
| 0 | |
| 0 |